[1]
Kulagowski, J.J.; Baker, R.; Curtis, N.R.; Leeson, P.D.; Mawer, I.M.; Moseley, A.M.; Ridgill, M.P.; Rowley, M.; Stansfield, I.; Foster, A.C.; Leeson, P.D. 3′-(Arylmethyl)- and 3′-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: Orally active antagonists of the glycine site on the NMDA receptor. J. Med. Chem., 1994, 37(10), 1402-1405.
[2]
Sharp, J. Antifungal methods employing certain carbostyrils., U.S.
Patent 3,836,657. 1974.
[3]
Magedov, I.V.; Manpadi, M.; Ogasawara, M.A.; Dhawan, A.S.; Rogelj, S.; Van Slambrouck, S.; Steelant, W.F.; Evdokimov, N.M.; Uglinskii, P.Y.; Elias, E.M.; Knee, E.J.; Tongwa, P.; Antipin, M.Y.; Kornienko, A. Structural simplification of bioactive natural products with multicomponent synthesis. 2. antiproliferative and antitubulin activities of pyrano[3,2-c]pyridones and pyrano[3,2-c]quinolones. J. Med. Chem., 2008, 51(8), 2561-2570.
[4]
McBrien, K.D.; Gao, Q.; Huang, S.; Klohr, S.E.; Wang, R.R.; Pirnik, D.M.; Neddermann, K.M.; Bursuker, I.; Kadow, K.F.; Leet, J.E. Fusaricide, a new cytotoxic N-hydroxypyridone from Fusarium sp. J. Nat. Prod., 1996, 59(12), 1151-1153.
[5]
Kamperdick, C.; Van, N.H.; Van Sung, T.; Adam, G. Bisquinolinone alkaloids from Melicope ptelefolia. Phytochemistry, 1999, 50(1), 177-181.
[6]
Chen, I-S.; Wu, S-J.; Tsai, I-L.; Wu, T-S.; Pezzuto, J.M.; Lu, M.C.; Chai, H.; Suh, N.; Teng, C-M. Chemical and bioactive constituents from Zanthoxylum simulans. J. Nat. Prod., 1994, 57(9), 1206-1211.
[7]
Kemnitzer, W.; Kasibhatla, S.; Jiang, S.; Zhang, H.; Zhao, J.; Jia, S.; Xu, L.; Crogan-Grundy, C.; Denis, R.; Barriault, N. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell-and caspase-based high-throughput screening assay. 2. Structure–activity relationships of the 7-and 5-, 6-, 8-positions. Bioorg. Med. Chem. Lett., 2005, 15(21), 4745-4751.
[8]
Gourdeau, H.; Leblond, L.; Hamelin, B.; Desputeau, C.; Dong, K.; Kianicka, I.; Custeau, D.; Boudreau, C.; Geerts, L.; Cai, S-X. Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4, 5-dimethoxy-phenyl)-3-cyano-4H-chromenes, a novel series of anticancer agents. Mol. Cancer Ther., 2004, 3(11), 1375-1384.
[9]
Kasibhatla, S.; Gourdeau, H.; Meerovitch, K.; Drewe, J.; Reddy, S.; Qiu, L.; Zhang, H.; Bergeron, F.; Bouffard, D.; Yang, Q. Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activity. Mol. Cancer Ther., 2004, 3(11), 1365-1374.
[10]
Kemnitzer, W.; Drewe, J.; Jiang, S.; Zhang, H.; Wang, Y.; Zhao, J.; Jia, S.; Herich, J.; Labreque, D.; Storer, R. Discovery of 4-Aryl-4 H-chromenes as a new series of apoptosis inducers using a cell-and caspase-based high-throughput screening assay. 1. structure-activity relationships of the 4-Aryl group. J. Med. Chem., 2004, 47(25), 6299-6310.
[11]
Kemnitzer, W.; Drewe, J.; Jiang, S.; Zhang, H.; Zhao, J.; Crogan-Grundy, C.; Xu, L.; Lamothe, S.; Gourdeau, H.; Denis, R. Discovery of 4-Aryl-4 H-chromenes as a New series of apoptosis inducers using a cell-and caspase-based high-throughput screening assay. 3. Structure-Activity relationships of fused rings at the 7, 8-positions. J. Med. Chem., 2007, 50(12), 2858-2864.
[12]
Cai, S.X.; Jiang, S.; Kemnitzer, W.E.; Zhang, H.; Attardo, G.; Denis, R. Substituted 4-aryl-4h-pyrrolo [2, 3-h] chromenes and
analogs as activators of caspases and inducers of apoptosis and the
use thereof. U.S. Patent 7,528,164. 2009.
[13]
Cai, S.X.; Jiang, S.; Attardo, G.; Denis, R.; Storer, R.; Rej, R. Substituted
4H-chromens, 2H-chromenes, chromans and analogs as activators
of caspases and inducers of apoptosis and the use thereof.
U.S. Patent 20,050,176,750. 2009.
[14]
Cai, S.X. Substituted 4H-chromenes and analogs as activators of
caspases and inducers of apoptosis and the use thereof. U.S. Patent
7,053,117, 2006.
[15]
Cai, S.X.; Zhang, H.; Kemnitzer, W.E.; Jiang, S.; Drewe, J.; Storer, R. Substituted coumarins and quinolines and analogs as activators
of caspases and inducers of apoptosis and the use thereof. U.S. Patent
7,235,674, 2006.
[16]
Drewe, J.A.; Cai, S.X.; Wang, Y. Substituted 4H-chromene and
analogs as activators of caspases and inducers of apoptosis and the
use thereof. WO Patent, 2,001,034,591, 2005.
[17]
Cai, S.X.; Xu, L.; Storer, R.; Attardo, G. 7, 8-fused 4H-chromene
and analogs as activators of caspases and inducers of apoptosis and
the use thereof. U.S. Patent 6,858,607, 2005.
[18]
Upadhyay, K.D.; Dodia, N.M.; Khunt, R.C.; Chaniara, R.S.; Shah, A.K. Synthesis and biological screening of pyrano[3,2-c]quinoline analogues as anti-inflammatory and anticancer agents. ACS Med. Chem. Lett., 2018, 9(3), 283-288.
[19]
Chaniyara, R.; Thakrar, S.; Kakadiya, R.; Marvania, B.; Detroja, D.; Vekariya, N.; Upadhyay, K.; Manvar, A.; Shah, A. DBU‐catalyzed multicomponent synthesis: Facile access of 4,5,6,9‐tetrahydro‐pyrido[3,2‐c]quinolines. J. Heterocycl. Chem., 2014, 51(2), 466-474.
[20]
Dengler, W.A.; Schulte, J.; Berger, D.P.; Mertelsmann, R.; Fiebig, H.H. Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays. Anticancer Drugs, 1995, 6(4), 522-532.
[21]
Dengler, W.A.; Schulte, J.; Berger, D.P.; Mertelsmann, R.; Fiebig, H.H. Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays. Anticancer Drugs, 1995, 6(4), 522-532.
[22]
Joshi, K.S.; Rathos, M.J.; Joshi, R.D.; Sivakumar, M.; Mascarenhas, M.; Kamble, S.; Lal, B.; Sharma, S. In vitro antitumor properties of a novel cyclin-dependent kinase inhibitor, P276-00. Mol. Cancer Ther., 2007, 6(3), 918-925.
[23]
Losiewicz, M.D.; Carlson, B.A.; Kaur, G.; Sausville, E.A.; Worland, P.J. Potent inhibition of Cdc2 kinase activity by the flavonoid L86-8275. Biochem. Biophys. Res. Commun., 1994, 201(2), 589-595.
[24]
Joshi, K.S.; Wagh, V.; Sharma, S. Herbal composition and process
for its preparation. U.S. Patent 8,137,708. 2012.
[25]
Kumar, S.; Vishwakarma, R.; Mundada, R.; Deore, V.; Kumar, P.; Sharma, S. Imidazo [4, 5-C] quinoline derivatives and their use in
the treatment of tumors and/or inflammation. U.S. Patent
13/381,464, 2012.